Home>Topics>Stocks>AstraZeneca PLC ADR

AstraZeneca PLC ADR AZN

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
    1. Nektar Therapeutics Has More To Give

      Headlines

      Thu, 21 Aug 2014

      By Stephen Simpson, CFA : [Editor's Note, August 21: This article has been revised since original publication, as the author has added extra content.] This year has seen biotechs on a rockier road, but those companies that have continued to develop broad pipelines have fared a little better. Nektar

    2. New Morningstar Analyst Report for Novartis AG

      Stock Reports

      Thu, 21 Aug 2014

      consistent growth versus a branded-only pharmaceutical company such as AstraZeneca . We are maintaining our fair value estimate of CHF 73 per share ..... consistent growth versus a branded-only pharmaceutical company such as AstraZeneca .

    3. Healthcare stocks lift UK's FTSE 100

      Headlines

      Thu, 21 Aug 2014

      * FTSE 100 up 0.3 pct, near 3-week high * AstraZeneca up on speculation over new Pfizer bid * Building supplies group CRH boosted by analyst upgrade * Miners lag after weak Chinese data By Tricia...

    4. Pfizer may make another run at AstraZeneca by year end

      Headlines

      Thu, 21 Aug 2014

      will rekindle its bid for AstraZeneca ( AZN +3% ) by late 2014. The British ..... being within 7% of the price AstraZeneca wanted. Under British takeover ..... restart as early as August 26 if AstraZeneca invites Pfizer back to the table

    5. Healthcare stocks lift UK's FTSE 100

      Headlines

      Thu, 21 Aug 2014

      * FTSE 100 up 0.2 pct, near 3-week high * AstraZeneca up on speculation over new Pfizer bid * Miners lag after weak Chinese data By Tricia Wright and Sudip Kar-Gupta LONDON, Aug 21 (Reuters) -...

    6. New Morningstar Analyst Report for AstraZeneca PLC

      Stock Reports

      Thu, 21 Aug 2014

      pricing power of the pipeline.While AstraZeneca doesn't have the largest presence ..... Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded ..... slightly less than 40% of its sales. AstraZeneca faces the typical risks inherent in

    7. Pfizer back for AstraZeneca ? Year-end move seen most likely

      Headlines

      Thu, 21 Aug 2014

      LONDON (Reuters) - Shares in drugmaker AstraZeneca have climbed more than 7 percent this week, fueled by speculation of renewed takeover interest from Pfizer, following an abortive $118 billion (71 billion pounds) takeover attempt in May.

    8. Ilumina collaborates with members of Big Pharma on molecular diagnostics

      Headlines

      Thu, 21 Aug 2014

      Ilumina (NASDAQ: ILMN ) has formed collaborative partnerships with AstraZeneca (NYSE: AZN ), Janssen Biotech (NYSE: JNJ ) and Sanofi (NYSE: SNY ) to develop a universal next-generation sequencing (NGS) system

    9. Healthcare stocks lift UK's FTSE 100

      Headlines

      Thu, 21 Aug 2014

      * FTSE 100 up 0.3 pct, near 3-week high * AstraZeneca up on speculation over new Pfizer bid * Miners lag after weak Chinese data By Tricia Wright and Sudip Kar-Gupta LONDON, Aug 21 (Reuters) -...

    10. Healthcare stocks lift UK's FTSE 100

      Headlines

      Thu, 21 Aug 2014

      * FTSE 100 up 0.2 pct, near 3-week high * AstraZeneca up on speculation over new Pfizer bid * Miners lag after weak Chinese data By Sudip Kar-Gupta LONDON, Aug 21 (Reuters) - Britain's top equity...

    « Prev12345Next »
    Content Partners